Physician profile
Antonio Luis
NPI 1396971370
$17,440.00
in general payments reported to CMS, 2019-2025
18 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2021: $228 · 2023: $374 · 2024: $988 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $3,254 · Travel and Lodging: $1,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,120.00 |
| Food and Beverage | $3,254.43 |
| Travel and Lodging | $1,237.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $15,169.22 | 2019-2025 | Descovy, Yeztugo, Biktarvy |
| Viiv Healthcare Company | $1,482.06 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Janssen Biotech, INC. | $113.04 | 2019-2021 | |
| Janssen Products, Lp | $99.99 | 2019 | |
| Theratechnologies INC. | $92.87 | 2021-2025 | Trogarzo, Egrifta |
| Emd Serono, INC. | $81.87 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $74.77 | 2019-2021 | |
| Antares Pharma, INC. | $59.17 | 2024-2025 | Xyosted |
| Novo Nordisk INC | $39.11 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Kowa Pharmaceuticals America, INC. | $34.08 | 2025 | Zoryve |
| Lilly USA, LLC | $33.06 | 2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $28.77 | 2023 | Trintellix |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Dynavax Technologies Corporation | $26.37 | 2021 | |
| Phathom Pharmaceuticals, INC. | $26.04 | 2025 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $18.91 | 2023 | Symtuza |
| Exact Sciences Corporation | $17.50 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $14.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Luis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.